Pfizer Is Changed ‘Forever’ By COVID-19; Revenue Forecast Hits Triple Digits

 
• By Jessica Merrill

The company could reach $100bn in revenues in 2022 for the first time, powered by Comirnaty and Paxlovid; actual sales for the COVID-19 products are likely to go higher based on supply contracts.

New York, July 19, 2016: Corporate lettering on the exterior of the Pfizer headquarters in Manhattan.
Pfizer has been reshaped by COVID-19 vaccines and therapeutics • Source: Alamy

More from COVID-19

More from Scrip